SOD1 and amyotrophic lateral sclerosis: Transgenic mice expressing the same SOD1 mutations as human, in particular the G93A point mutation, exhibit similar histopathological and clinical phenotypes as ALS patients [4], [5], and hence have been widely used to elucidate mechanisms inducing ALS pathology as well as to screen for potential therapeutics [4].